0001493152-24-029941.txt : 20240801 0001493152-24-029941.hdr.sgml : 20240801 20240801171510 ACCESSION NUMBER: 0001493152-24-029941 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240801 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTELLIGENT BIO SOLUTIONS INC. CENTRAL INDEX KEY: 0001725430 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 821512711 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39825 FILM NUMBER: 241167865 BUSINESS ADDRESS: STREET 1: 142 WEST 57TH ST FL11 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-233-6971 MAIL ADDRESS: STREET 1: 142 WEST 57TH ST FL11 CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: GBS Inc. DATE OF NAME CHANGE: 20190919 FORMER COMPANY: FORMER CONFORMED NAME: Glucose Biosensor Systems (Greater China) Holdings, Inc. DATE OF NAME CHANGE: 20171214 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 1, 2024

INTELLIGENT BIO SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39825		82-1512711
(State of Incorporation)		(Commission File Number)		(IRS employer identification no.)

135 West, 41^st Street, 5^thFloor, New York, NY 10036

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (646) 828-8258

142 West, 57^th Street, 11th Floor, New York, NY 10019

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		INBS		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On August 1, 2024, Intelligent Bio Solutions Inc. (the “Company”) issued a press release (the “Press Release”) announcing that CenExel, a nationwide clinical research site network, will perform a method comparison clinical study as part of the Company’s FDA 510(k) clinical study plan. A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing disclosure is qualified in its entirety by the full text of the Press Release.

The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purpose of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.

Item 9.01 Financial Statements and Exhibits.

No.		Description
99.1		Press release dated August 1, 2024
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 1, 2024
	INTELLIGENT BIO SOLUTIONS INC.

	By:	/s/ Spiro Sakiris
	Name:	Spiro Sakiris
	Title:	Chief Financial Officer

EX-99.1 2 ex99-1.htm

Exhibit 99.1

Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway

NEW YORK, August 1, 2024 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its partnership with CenExel, a nationwide clinical research site network, to perform a method comparison clinical study as part of the Company’s FDA 510(k) clinical study plan.

The Company’s method comparison study will recruit 135 healthy adult subjects across three sites under an IRB-approved protocol and compare the results of fingerprint sweat opiate screening tests to the results from a validated, traceable liquid chromatography mass spectrometry (LC-MS/MS) method, widely accepted as the gold standard for such studies.

Harry Simeonidis, President and CEO of Intelligent Bio Solutions, commented, “We are pleased to announce our partnership with CenExel and the initiation of the method comparison study, marking the final phase in our clinical study plan. Over the past two months, we have made substantial progress and are steadily getting closer to filing our 510(k) submission with the FDA. We remain on track for our planned submission to the FDA in the fourth quarter of this calendar year. I commend our dedicated team and clinical study partners for their immense effort and commitment to ensuring the smooth execution of our clinical study plan.” Stuart Goldblatt, Chief Executive Officer at CenExel, stated, “CenExel is excited to commence this clinical trial to test this innovative device with the potential to provide rapid and non-invasive testing for opiates.”

The Company recently completed the in-clinic portion of a pharmacokinetic (PK) study on opiates in human fingerprint sweat. Through the method comparison study, the Company intends to demonstrate that the Intelligent Fingerprinting Drug Screening System, which comprises the Intelligent Fingerprinting Drug Screening Cartridge and DSR-Plus fluorescence reader, performs accurately in the hands of intended users to detect the presence of opiates. The Company plans to commence the method comparison study in August 2024.

About CenExel

CenExel provides unparalleled medical and scientific support in the design and execution of clinical trials. CenExel’s therapeutic area focus, attention to detail, and auxiliary services assure quality, reliable results and help it to consistently achieve and exceed patient recruitment goals. CenExel Centers of Excellence have conducted thousands of studies, the variety and complexity of which have resulted in a vast depth of experience and insight for the Principal Investigators and research staff in each facility. The CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure clients achieve their clinical research goals.

About Intelligent Bio Solutions Inc. 

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for various indications, ranging from immunological conditions to communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners. 

For more information, visit: http://www.ibs.inc/

 

Forward-Looking Statements: 

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions’ public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events. 

Company Contact:

Intelligent Bio Solutions Inc. 

info@ibs.inc

LinkedIn | Twitter 

Investor & Media Contact:

Valter Pinto, Managing Director

KCSA Strategic Communications

PH: (212) 896-1254

INBS@kcsa.com

EX-101.SCH 3 inbs-20240801.xsd 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 inbs-20240801_def.xml EX-101.LAB 5 inbs-20240801_lab.xml Entity Addresses, Address Type [Axis] Former Address [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 inbs-20240801_pre.xml XML 8 R1.htm IDEA: XBRL DOCUMENT

Cover	Aug. 01, 2024
Entity Addresses [Line Items]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Aug. 01, 2024
Entity File Number	001-39825
Entity Registrant Name	INTELLIGENT BIO SOLUTIONS INC.
Entity Central Index Key	0001725430
Entity Tax Identification Number	82-1512711
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	135 West, 41st Street
Entity Address, Address Line Two	5th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	(646)
Local Phone Number	828-8258
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	INBS
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Former Address [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	142 West, 57th Street
Entity Address, Address Line Two	11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10019

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 2 24 1 false 1 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ibs.inc/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm inbs-20240801.xsd inbs-20240801_def.xml inbs-20240801_lab.xml inbs-20240801_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "INBS", "nsuri": "http://ibs.inc/20240801", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "inbs-20240801.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "inbs-20240801_def.xml" ] }, "labelLink": { "local": [ "inbs-20240801_lab.xml" ] }, "presentationLink": { "local": [ "inbs-20240801_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 64, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 29 }, "report": { "R1": { "role": "http://ibs.inc/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-08-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-08-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AddressTypeDomain", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r15" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r15" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r14", "r15" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r17" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesLineItems", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesTable", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r2" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r21" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r18" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r15" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r19" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_FormerAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "FormerAddressMember", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Former Address [Member]", "documentation": "Former address for entity" } } }, "auth_ref": [ "r13", "r16" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r14" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r20" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "249", "Section": "308", "Subsection": "a" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Number": "249", "Section": "308" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-24-029941-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-029941-xbrl.zip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end XML 17 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001725430 2024-08-01 2024-08-01 0001725430 dei:FormerAddressMember 2024-08-01 2024-08-01 iso4217:USD shares iso4217:USD shares false 0001725430 8-K 2024-08-01 INTELLIGENT BIO SOLUTIONS INC. DE 001-39825 82-1512711 135 West, 41st Street 5th Floor New York NY 10036 (646) 828-8258 142 West, 57th Street 11th Floor New York NY 10019 false false false false Common Stock, $0.01 par value INBS NASDAQ true false